Primary |
Idiopathic Thrombocytopenic Purpura |
35.7% |
Small Intestine Carcinoma |
10.0% |
Hypertension |
9.0% |
Constipation |
6.2% |
Immune Thrombocytopenic Purpura |
6.2% |
Postoperative Care |
4.3% |
Prophylaxis |
3.8% |
Product Used For Unknown Indication |
3.3% |
Haematochezia |
2.9% |
Diabetes Mellitus |
2.4% |
Gastritis |
2.4% |
Insomnia |
1.9% |
Osteoporosis |
1.9% |
Angina Pectoris |
1.4% |
Diarrhoea |
1.4% |
Gastric Ulcer |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Hyperlipidaemia |
1.4% |
Hyperuricaemia |
1.4% |
Mitral Valve Replacement |
1.4% |
|
Platelet Count Decreased |
9.1% |
Therapeutic Response Decreased |
9.1% |
Cerebral Haemorrhage |
7.3% |
Death |
7.3% |
Antibody Test |
5.5% |
Arteriosclerosis Obliterans |
5.5% |
Asthma |
5.5% |
Cerebral Infarction |
5.5% |
Thrombosis |
5.5% |
Anaemia Haemolytic Autoimmune |
3.6% |
Azotaemia |
3.6% |
Hepatic Function Abnormal |
3.6% |
Influenza Like Illness |
3.6% |
Myelofibrosis |
3.6% |
Myocardial Infarction |
3.6% |
Petechiae |
3.6% |
Pneumocystis Jiroveci Pneumonia |
3.6% |
Pneumonia |
3.6% |
Respiratory Failure |
3.6% |
Soft Tissue Infection |
3.6% |
|
Secondary |
Idiopathic Thrombocytopenic Purpura |
47.1% |
Epilepsy |
7.4% |
Gastritis |
7.4% |
Osteoporosis |
7.4% |
Diabetes Mellitus |
5.9% |
Diarrhoea |
4.4% |
Prophylaxis |
4.4% |
Hypertension |
2.9% |
Immune Thrombocytopenic Purpura |
2.2% |
Angina Pectoris |
1.5% |
Benign Prostatic Hyperplasia |
1.5% |
Orthostatic Hypotension |
1.5% |
Spinal Osteoarthritis |
1.5% |
Atrial Fibrillation |
0.7% |
Cardiac Failure |
0.7% |
Constipation |
0.7% |
Gastric Ulcer |
0.7% |
Neuropathy Peripheral |
0.7% |
Peripheral Arterial Occlusive Disease |
0.7% |
Thrombosis |
0.7% |
|
Liver Disorder |
23.3% |
Antibody Test |
10.5% |
Haemorrhage Intracranial |
10.5% |
Thrombosis |
10.5% |
Renal Impairment |
7.0% |
Anaemia Haemolytic Autoimmune |
5.8% |
Myelofibrosis |
5.8% |
Hypotension |
4.7% |
Therapeutic Response Decreased |
4.7% |
White Blood Cell Count Increased |
4.7% |
Petechiae |
3.5% |
Azotaemia |
2.3% |
Disseminated Intravascular Coagulation |
2.3% |
Hepatic Function Abnormal |
2.3% |
Pulmonary Artery Thrombosis |
2.3% |
|
Concomitant |
Idiopathic Thrombocytopenic Purpura |
100.0% |
|
Pulmonary Haemorrhage |
100.0% |
|